rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2008-11-3
|
pubmed:abstractText |
Chemo-radiation is considered the standard procedure for the management of limited disease small-cell lung cancer (SCLC). Controversy remains as to when surgery should be considered. We sought to determine the survival after complete resection of SCLC and the prognostic impact of clinical and pathologic stage.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1556-1380
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1267-71
|
pubmed:dateRevised |
2009-4-27
|
pubmed:meshHeading |
pubmed-meshheading:18978561-Adult,
pubmed-meshheading:18978561-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18978561-Combined Modality Therapy,
pubmed-meshheading:18978561-Evaluation Studies as Topic,
pubmed-meshheading:18978561-Female,
pubmed-meshheading:18978561-Humans,
pubmed-meshheading:18978561-Lung Neoplasms,
pubmed-meshheading:18978561-Lymph Node Excision,
pubmed-meshheading:18978561-Lymph Nodes,
pubmed-meshheading:18978561-Lymphatic Metastasis,
pubmed-meshheading:18978561-Male,
pubmed-meshheading:18978561-Middle Aged,
pubmed-meshheading:18978561-Neoplasm Staging,
pubmed-meshheading:18978561-Radiotherapy Dosage,
pubmed-meshheading:18978561-Retrospective Studies,
pubmed-meshheading:18978561-Small Cell Lung Carcinoma,
pubmed-meshheading:18978561-Survival Rate,
pubmed-meshheading:18978561-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate.
|
pubmed:affiliation |
Imperial College and Academic Division of Thoracic Surgery and Histopathology, Royal Brompton Hospital, London, UK. e.lim@rbht.nhs.uk
|
pubmed:publicationType |
Journal Article
|